Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Thu, Apr 17, 2025 01:27 AM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

Paul Lushenko

Assistant Professor and Director of Special Operations, US Army War College
LTC Paul Lushenko is an Assistant Professor and Director of Special Operations at the U.S. Army War College. He earned his Ph.D. and M.A. in International Relations from Cornell University. He also holds an M.A. in Defense and Strategic Studies from the U.S. Naval War College, an M.A. in International Relations and a Master of Diplomacy from The Australian National University, and a B.S. from the U.S. Military Academy. Paul has deployed continuously, directing intelligence operations at the Battalion, Combined Task Force, and Joint Task Force levels. In his most recent operational assignment, Paul served as the Senior Intelligence Officer for the Joint Special Operations Task Force in Afghanistan, and was also responsible for shaping the coalition’s strategy to defeat the Islamic State and helping to regionalize U.S. counterterrorism policy and strategy. Paul is a Council on Foreign Relations Term Member, Adjunct Research Lecturer at Charles Sturt University, and Non-Resident Senior Fellow at Cornell University’s Tech Policy Institute. He is the co-editor of Drones and Global Order: Implications of Remote Warfare for International Society (2022), which is the first book to systematically study the implications of drone warfare on global politics. He also has a book forthcoming on the public’s perceptions of legitimate drone strikes, entitled The Legitimacy of Drone Warfare: Evaluating Public Perceptions (2024).

US drone warfare faces questions of legitimacy, study of military chaplains shows

May 09, 2024 07:10 am UTC| Insights & Views Technology

Are drone strikes legitimate, meaning on sound moral and legal footing? How people perceive the legitimacy of U.S. drone strikes firing missiles from remotely piloted aircraft at terrorist and insurgent leaders is...

Cult of the drone: At the two-year mark, UAVs have changed the face of war in Ukraine – but not outcomes

Feb 20, 2024 11:15 am UTC| Insights & Views

Unmanned aerial vehicles, or drones, have been central to the war in Ukraine. Some analysts claim that drones have reshaped war, yielding not just tactical-level effects, but shaping operational and strategic outcomes as...

Economy

New Zealand Cuts RBNZ Budget by 25% Amid Public Sector Austerity Drive

New Zealands government will reduce the Reserve Bank of New Zealands (RBNZ) annual operating budget by around 25% in the upcoming fiscal year, capping it at NZ$150 million (US$88.5 million) annually over the next five...

Asian Markets Tumble as Trade Tensions and Chip Curbs Cloud Economic Outlook

Asian markets dropped Wednesday as Nvidia shares plunged following U.S. restrictions on AI chip exports to China, fueling fears of an expanding U.S.-China tech war. The news wiped out $160 billion from Nvidias market cap,...

China’s Q1 2025 GDP Beats Forecasts Despite Trade War Pressures

Chinas economy expanded more than expected in the first quarter of 2025, with GDP growing 5.4% year-on-year, surpassing market forecasts of 5.2%, according to official data released Wednesday. The stronger performance was...

Oil Prices Steady Amid Trade War Fears and Slowing Global Demand

Oil prices held steady early Wednesday as uncertainty over escalating U.S.-China trade tensions and their potential impact on global economic growth kept markets cautious. Brent crude futures edged up 5 cents to $64.72 per...

Dollar Stabilizes Ahead of Powell Speech and China GDP Data

The U.S. dollar held onto modest gains early Wednesday as markets paused after weeks of sharp selling and ahead of key economic events. Investors are watching for updates on U.S.-China trade talks, while attention also...

Politics

Biden Slams Trump Over Social Security Cuts in First Major Speech Since Leaving Office

Former President Joe Biden made a high-profile return to the political stage Tuesday, criticizing the Trump administrations deep cuts to the Social Security Administration (SSA). Speaking in Chicago to disability...

Trump Proposes Cash Incentives for Voluntary Immigrant Departures

U.S. President Donald Trump revealed plans for a new immigration initiative offering financial incentives to undocumented immigrants who choose to leave the country voluntarily. In an interview aired Tuesday on Fox...

Trump Administration Limits Wire Service Access to White House Press Pool

The Trump administration has removed wire services including Reuters, Bloomberg, and the Associated Press (AP) from their permanent positions in the White House press pool, altering decades of precedent and raising...

Australian Politicians Received $147K in Sports Tickets Amid Anti-Gambling Ad Lobbying

Australian lawmakers were gifted approximately A$245,000 (US$147,000) worth of sports tickets over 21 months by the countrys top sporting leagues, as part of an effort to lobby against a proposed ban on online gambling...

Pentagon Adviser Dan Caldwell Removed Amid Leak Probe

Dan Caldwell, a top adviser to U.S. Defense Secretary Pete Hegseth, was escorted from the Pentagon and placed on administrative leave following an investigation into an unauthorized disclosure, according to a U.S....

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

U.S. Imposes New Export Curbs on Nvidia and AMD AI Chips to China

The U.S. Commerce Department announced new export licensing requirements on Tuesday targeting Nvidias H20 and AMDs MI308 artificial intelligence chips, along with equivalent models, restricting their shipment to China. The...

TSMC Nears Breakthrough in Advanced Chip Packaging to Power AI Growth

Taiwan Semiconductor Manufacturing Co. (TSMC), the worlds leading contract chipmaker, is nearing completion of a cutting-edge chip packaging technology to meet surging demand for high-performance AI chips, according to...

Blue Origin Boosts Space Tourism with Katy Perry on Historic All-Female Flight

Pop star Katy Perry and five other trailblazing women successfully completed a historic suborbital spaceflight aboard Blue Origins New Shepard rocket on April 14, marking the first all-female space mission in over 60...

AMD Ready to Begin Chip Production in Arizona Amid AI Server Expansion

Advanced Micro Devices (NASDAQ:AMD) CEO Lisa Su confirmed on Tuesday that the company is prepared to begin chip production at its Arizona facility. Speaking at National Taiwan University in Taipei, Su emphasized AMDs...

Nvidia to Manufacture AI Supercomputers in the U.S. with TSMC and Foxconn

Nvidia (NASDAQ: NVDA) announced plans to manufacture AI supercomputers entirely in the U.S. for the first time, marking a major shift in its production strategy. The company has secured over one million square feet of...